The finnCap Slide Rule UCITS Fund (“The Fund”) is a newly-launched open-ended fund which seeks to deliver capital growth through a quantitative approach to investing in UK-listed smaller companies.

Investment philosophy and strategy

The UK smaller companies universe is full of excellent investment opportunities but it is very large (1,500+ stocks) and suffers from limited and inconsistent research coverage. The finnCap solution is an internally-developed investment analysis tool, The Slide Rule, to dramatically simplify the identification of the best companies. Using The Slide Rule, finnCap has developed a stock picking system, called QVGM+, which is used to find the “best” 80-100 stocks. It is these companies into which the fund will invest. The system’s core factors are Quality, Value, Growth and Momentum plus a screen for financial quality and stress. The typical company in the resultant portfolio is one with above average growth and above average ROCE (return on capital employed).

Simulated Performance

Back-tested to the beginning of 2014, the investment strategy (“The Strategy”) has delivered gross total return of 22.4%* p.a., significantly outperforming the 6.1% p.a. total return of the benchmark index (“The Benchmark”, an equal-weighted average of the FTSE AIM All Share and FTSE Small Cap index).  Additionally, The Strategy has outperformed The Benchmark in 15 out of 16 quarters since ‘inception’ and was up 7.3% in 2014, a year when The Benchmark was down 9.5%.



finnCap Slide Rule UCITS Fund


The UK smaller companies universe is full of excellent investment opportunities but it is very large (1,500+ stocks) and suffers from limited and inconsistent research coverage. It can thus be difficult to navigate but exceptional investment opportunities exist in this universe.


The Fund uses a rigorously developed, quantitative, stock picking system to invest in the “best” 80-100 stocks within this universe. The “best” companies are those displaying the highest growth coupled with the highest return on capital.


Simulated performance has been strong and consistent. Back-tested to the beginning of 2014, the investment strategy has delivered CAGR of 22.4%, significantly outperforming the 6.1% CAGR of The Benchmark. Further, the investment strategy has outperformed The Benchmark in 15 quarters out of the 16 quarters analysed.

Terms and Conditions Apply

Read the disclaimer

MontLake Asset Management Ltd, 23 St. Stephen's Green, Dublin 2, D02 AR55, Ireland is licensed to provide Investment Management services to Professional Clients (including Collective Investment Schemes) by the Central Bank of Ireland.

MontLake UCITS Platform ICAV is an umbrella open-ended Irish collective asset-management vehicle with segregated liability between Funds formed in Ireland under the Irish Collective Asset-management Vehicles Act 2015 and authorised by the Central Bank as a UCITS pursuant to the UCITS Regulations.

The Manager of MontLake UCITS Platform ICAV is MontLake Management Ltd, a company regulated by the Central Bank of Ireland. 

This website is directed mainly for professional and institutional clients who possess the necessary experience, knowledge and expertise to make their own investment decisions and properly assess the risk that it incurs.

Information on this website was obtained from various sources and the company does not guarantee its accuracy. The information is for your private use and discussion purposes only and expressed views and opinions may change.

The Performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. The value of your investment and their income may go down as well as up.

Your investment may also be subject to currency, interest rate, as well as market fluctuations. Consequently the Investor may not get back a sum equal to that he / she originally invested.

Investors should note that an investment in those Sub-Funds which may invest in emerging markets should not constitute a substantial proportion of an investment portfolio and may not be appropriate for all investors.

The Sub-Funds may invest in Over the Counter as well as Exchange Traded derivative instruments to enhance return or hedge against fluctuations in security prices or market rates as well as to short sell a security through the use of a derivative instrument. Transactions in derivative instruments involve a risk of loss or depreciation of capital due to adverse changes in security prices, exchange rates or interest rates or in the case of OTC instruments default of Counterparty. This investment may not be suitable for all types of investors. It is therefore recommended that you consult your investment advisor.

A commission or sales fee may be charged at the time of the initial purchase for an investment and may be deducted from the invested amount therefore lowering the size of your investment. The Investment Manager will be entitled to receive a performance fee as well as a management fee, calculated on a daily basis and paid quarterly by the sub-funds.

The Levels and bases of taxation are dependent on individual circumstances and subject to change and therefore it is highly recommended that you consult a professional tax advisor.